TABLE 3.
Characteristics Associated With 12 and 24 Month Postpartum HIV Viral Suppression Among Women Living with HIV in the UCHCC, 1996–2014 (N=141)
| 12 Month Suppression | 24 Month Suppression | |||
|---|---|---|---|---|
| Characteristic* | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
| Age ≥30 years | 3.16 (1.56, 6.42) | 2.74 (1.17, 6.41) | 2.92 (1.33, 6.41) | 2.52 (1.02, 6.22) |
| Race | ||||
| White, non-Hispanic | 1.28 (0.54, 3.01) | -- | 2.34 (0.91, 5.97) | 2.27 (0.75, 6.88) |
| Black, non-Hispanic | ref | -- | ref | ref |
| Other | 1.42 (0.58, 3.50) | -- | 2.50 (0.94, 6.65) | 2.55 (0.83, 7.82) |
| Antenatal HIV diagnosis | 1.28 (0.61, 2.70) | -- | 1.01 (0.43, 2.36) | -- |
| HIV RNA <400 copies/mL | 10.11 (2.87, 35.57) | 6.12 (1.53, 24.45) | 7.50 (1.68, 33.51) | 6.42 (1.29, 31.97) |
| CD4 count, per 100 cell/mm3 increase | 1.07 (0.93, 1.22) | -- | 1.08 (0.93, 1.25) | -- |
| Antenatal ART use | ||||
| <12 weeks | 0.36 (0.12,1.06) | 0.67 (0.18, 2.48) | 0.53 (0.17, 1.72) | -- |
| 12–38 weeks | ref | ref | ref | -- |
| ≥38 weeks | 0.97 (0.42, 2.28) | 0.86 (0.28, 2.60) | 0.85 (0.32, 2.24) | -- |
| Calendar year of delivery | ||||
| 1996–2001 | 0.61 (0.26, 1.41) | 0.72 (0.22, 2.33) | 0.80 (0.31, 2.04) | 1.25 (0.36, 4.33) |
| 2002–2008 | ref | ref | ref | ref |
| 2009–2014 | 2.73 (1.14, 6.52) | 2.16 (0.83, 5.58) | 1.92 (0.76, 4.85) | 1.45 (0.54, 3.94) |
| Gravidity | ||||
| 1 | 0.99 (0.30, 3.22) | -- | 0.89 (0.23, 3.46) | -- |
| ≥2 | ref | -- | ref | -- |
Abbreviations. OR, odds ratio; CI, confidence interval; ART, antiretroviral therapy.
*
All characteristics measured at delivery except HIV care visit within 60 days. HIV care retention based on the Institute of Medicine criteria.